DNA microarray for genotyping multidrug-resistant Pseudomonas aeruginosa clinical isolates

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Multidrug-resistant Pseudomonas aeruginosa infections require rapid antibiotic susceptibility testing for effective therapy.
• Current methods can be time-consuming, delaying critical treatment decisions for patients.

Purpose of the Study:

• To develop a fast and reliable DNA microarray for genotyping antibiotic resistance and virulence factors in Pseudomonas aeruginosa.
• To improve the management of infections caused by multidrug-resistant strains.

Main Methods:

• Development of a DNA microarray targeting specific resistance genes (mexR, nfxB, mexT, gyrA, parC, vim, imp, oxa, aph, aac, aad) and virulence factors (mucA, exoU, exoT, exoS).
• Procedure includes DNA isolation, gene amplification, fluorescence labeling, fragmentation, and array hybridization.
• The entire process is completed in under 5 hours.

Main Results:

• The developed DNA microarray successfully genotypes key antibiotic resistance and virulence factors.
• Genotype-phenotype comparison showed 87.8% coverage of relevant resistance determinants for antibiotic therapy in critically ill patients.
• The rapid turnaround time of less than 5 hours facilitates timely clinical decisions.

Conclusions:

• The DNA microarray offers a fast and reliable method for identifying resistance and virulence in Pseudomonas aeruginosa.
• This technology can significantly aid in optimizing antibiotic therapy for multidrug-resistant infections.
• The assay provides valuable genetic information for clinical management and infection control.